期刊文献+

溶血磷脂酸在不同类型急性脑梗死患者血浆中含量变化的意义 被引量:1

下载PDF
导出
摘要 目的:探讨血浆溶血磷脂酸(LPA)在不同类型急性脑梗死(ACI)患者中的变化规律及临床意义。方法:选择ACI患者(发病72 h)120例,对照组50例,进行血浆LPA水平的测定,并对不同类型ACI患者血浆LPA水平进行分析比较。结果:ACI患者血浆LPA含量明显高于对照组(P<0.01)。在ACI患者中大梗死灶、中梗死灶ACI患者组血浆LPA含量明显高于小梗死ACI患者(P<0.01),进展性脑卒中组血浆LPA明显高于完全性脑卒中组(P<0.01)。并在TOAST分型中,血浆LPA水平心源性栓塞型最高,其次为大动脉粥样硬化型,小动脉闭塞型最低;与小动脉闭塞型比较,心源性栓塞、大动脉粥样硬化型显著增高(均P<0.05)。结论:血浆LPA在脑梗死急性期明显升高,且在不同类型ACI患者中含量有所不同,故血浆LPA水平可作为脑梗死预报、病因诊断及病情评估的指标之一。
出处 《中国民康医学》 2012年第3期300-301,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献10

  • 1Pages C, Simon MF, Valet P, et al. Lysophosphatidie acid synthe- sis and release [ J ]. Prostaglandins Other Lipid Mediat, 2001,64 : 1 -10.
  • 2Moolenaar WH. Lysophosphatidic acid, a multifunctional phospho- lipid messenger[J]. J Biol Chem, 1995, 270(22) : 12949 - 12952.
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 4Pullicino P, NelsonRF, Kenall BE, et al. Small deep infarcts diag- nosed on computed tomography, 1980,30 : 1090.
  • 5Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicent- cr clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treat- ment. Stroke, 1993,24:35 -41.
  • 6Siess W. Athero - and thrombogenic actions of lysophosphatidic Acid and sphingosine -1 -phosphate[ J]. Biochim Biophys Ac- ta ,2002,1582:204.
  • 7Siess W, Tigyi G. Thrombogenic and atherogenic activities of lyso- phosphatidic acid. J Cell Biochem, 2004,92(6) : 1086 -1094.
  • 8Xu YJ, Aziz OA, Bhugra P, et al. Potential role of lysophospha- tidic acid in hypertension and atherosclerosis[ J]. Can J Cardiol, 2003, 19(13): 1525-1536.
  • 9Eichholtz T, Jalink K, Fahrenfort I, et al. The bioactive phospho- lipid lysophosphatidic acid is released from activated latelets, Bio- chem[J] , 1993,291 : 677 -682.
  • 10Holtsberg FW, Steiner MR, Keller JN, et al. Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons [ J ]. J Neurochem, 1998,70:66-76.

共引文献33021

同被引文献25

  • 1Chun, J. , et al. , International Union of Basic and Clinical Pharmacolo- gy. LXXV Ⅲ. Lysophospholipid receptor nomenclature [ J]. Pharmacol Rev,2010. 62(4) :579-587.
  • 2Smyth, S. S. , et al. Roles of lysophosphatidic acid in cardiovascular physiology and disease [ J ]. Biochim Biophys Acta, 2008,1781 ( 9 ) : 563 -570.
  • 3Rancoule,C. ,et al. Lysophosphatidic acid-l-receptor targeting agents for fibrosis[J]. Expert Opin lnvestig Drugs ,2011,20 (5) :657-667.
  • 4Noguchi, K. , et al. Lysophosphatidic acid ( LPA ) and its receptors [ J]. Curr Opin Pharmacol,2009,9( 1 ) : 15-23.
  • 5Kurth, T. , H. Chabriat and M. G. Bousser, Migraine and stroke: a complex association with clinical implications [ J ]. Lancet Neurol, 2012,11 ( 1 ) :92-100.
  • 6Schurks, M. , et al. Migraine and mortality: a systematic review and meta-analysis[ J]. Cephalalgia,2011,31 (12) :1301-1314.
  • 7Li, Z. G. , et al. , Influence of acetylsalicylate on plasma lysophospha- tidic acid level in patients with ischemic cerebral vascular diseases [J]. Neurol Res,2008,30(4) :366-369.
  • 8Kopp, U, C. ,M. Z. Cicha and S. Y. Jones, Activation of endothelin A receptm,'s contributes to impaired responsiveness of renal mechanosen- sory nerves in congestive heart failure[ Jl. Can J Physiol Pharmacol, 2010,88(6) :622-629.
  • 9Goto,T. ,et al. Endothelin receptor antagonist attenuates inflammatory response and prolongs the survival time in a neonatal sepsis model [J]. Intensive Care Med,2010,36(12) :2132-2139.
  • 10Meens, M. J. , et al. Calcitonin gene-related peptide terminates long- lasting vasopressor responses to endothelin 1 iu vivo [J]. Hyperten- sion ,2011,58( 1 ) :99-106.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部